Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Lancet. 2020 Mar 21;395(10228):973-984. doi: 10.1016/S0140-6736(20)30166-5.
Tens of millions of children are exposed to Mycobacterium tuberculosis globally every year; however, there are no contemporary estimates of the risk of developing tuberculosis in exposed children. The effectiveness of contact investigations and preventive therapy remains poorly understood.
In this systematic review and meta-analysis, we investigated the development of tuberculosis in children closely exposed to a tuberculosis case and followed for incident disease. We restricted our search to cohort studies published between Jan 1, 1998, and April 6, 2018, in MEDLINE, Web of Science, BIOSIS, and Embase electronic databases. Individual-participant data and a pre-specified list of variables were requested from authors of all eligible studies. These included characteristics of the exposed child, the index case, and environmental characteristics. To be eligible for inclusion in the final analysis, a dataset needed to include: (1) individuals below 19 years of age; (2) follow-up for tuberculosis for a minimum of 6 months; (3) individuals with household or close exposure to an individual with tuberculosis; (4) information on the age and sex of the child; and (5) start and end follow-up dates. Studies assessing incident tuberculosis but without dates or time of follow-up were excluded. Our analysis had two primary aims: (1) estimating the risk of developing tuberculosis by time-period of follow-up, demographics (age, region), and clinical attributes (HIV, tuberculosis infection status, previous tuberculosis); and (2) estimating the effectiveness of preventive therapy and BCG vaccination on the risk of developing tuberculosis. We estimated the odds of prevalent tuberculosis with mixed-effects logistic models and estimated adjusted hazard ratios (HRs) for incident tuberculosis with mixed-effects Poisson regression models. The effectiveness of preventive therapy against incident tuberculosis was estimated through propensity score matching. The study protocol is registered with PROSPERO (CRD42018087022).
In total, study groups from 46 cohort studies in 34 countries-29 (63%) prospective studies and 17 (37%) retrospective-agreed to share their data and were included in the final analysis. 137 647 tuberculosis-exposed children were evaluated at baseline and 130 512 children were followed for 429 538 person-years, during which 1299 prevalent and 999 incident tuberculosis cases were diagnosed. Children not receiving preventive therapy with a positive result for tuberculosis infection had significantly higher 2-year cumulative tuberculosis incidence than children with a negative result for tuberculosis infection, and this incidence was greatest among children below 5 years of age (19·0% [95% CI 8·4-37·4]). The effectiveness of preventive therapy was 63% (adjusted HR 0·37 [95% CI 0·30-0·47]) among all exposed children, and 91% (adjusted HR 0·09 [0·05-0·15]) among those with a positive result for tuberculosis infection. Among all children <5 years of age who developed tuberculosis, 83% were diagnosed within 90 days of the baseline visit.
The risk of developing tuberculosis among exposed infants and young children is very high. Most cases occurred within weeks of contact investigation initiation and might not be preventable through prophylaxis. This suggests that alternative strategies for prevention are needed, such as earlier initiation of preventive therapy through rapid diagnosis of adult cases or community-wide screening approaches.
National Institutes of Health.
每年都有数千万儿童在全球接触结核分枝杆菌; 然而,目前尚无关于接触者患结核病风险的估计。接触者调查和预防性治疗的效果仍知之甚少。
在这项系统评价和荟萃分析中,我们调查了密切接触结核病例并随访发病情况的儿童发生结核病的情况。我们将搜索范围限制在 1998 年 1 月 1 日至 2018 年 4 月 6 日期间发表的 MEDLINE、Web of Science、BIOSIS 和 Embase 电子数据库中的队列研究。我们向所有合格研究的作者请求了个体参与者数据和预先指定的变量列表。这些包括暴露儿童、索引病例和环境特征的特征。为了有资格纳入最终分析,数据集需要包括:(1)年龄在 19 岁以下的个体;(2)结核病随访至少 6 个月;(3)与个体有家庭或密切接触的个体患有结核病;(4)儿童的年龄和性别信息;(5)开始和结束随访日期。评估发病结核病但无随访日期或时间的研究被排除在外。我们的分析有两个主要目的:(1)根据随访时间、人口统计学(年龄、地区)和临床特征(HIV、结核感染状况、既往结核病)估计发生结核病的风险;(2)估计预防性治疗和卡介苗接种对发生结核病风险的影响。我们使用混合效应逻辑模型估计现患结核病的几率,并使用混合效应泊松回归模型估计发病结核病的调整后危害比(HR)。通过倾向评分匹配来估计预防性治疗对发病结核病的效果。研究方案已在 PROSPERO(CRD42018087022)中注册。
共有来自 34 个国家的 46 项队列研究的研究小组同意分享他们的数据并纳入最终分析,其中 29 项(63%)为前瞻性研究,17 项(37%)为回顾性研究。137647 名接触结核的儿童在基线时进行了评估,130512 名儿童随访了 429538 人年,在此期间诊断出 1299 例现患结核病和 999 例发病结核病。结核感染阳性结果但未接受预防性治疗的儿童,2 年累积结核病发病率明显高于结核感染阴性结果的儿童,且这一发病率在 5 岁以下儿童中最高(19.0%[95%CI 8.4-37.4])。所有接触者的预防性治疗效果为 63%(调整后 HR 0.37[95%CI 0.30-0.47]),结核感染阳性者的预防性治疗效果为 91%(调整后 HR 0.09[0.05-0.15])。所有<5 岁发病的儿童中,83%在基线就诊后 90 天内被诊断出。
接触的婴儿和幼儿患结核病的风险非常高。大多数病例发生在接触者调查开始后的几周内,可能无法通过预防来预防。这表明需要采取替代的预防策略,例如通过快速诊断成人病例或社区范围的筛查方法尽早开始预防性治疗。
美国国立卫生研究院。